Sovran Advisors »

Lenz Therapeutics shares owned by Sovran Advisors

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Sovran Advisors from 13F filings

Historical chart of Sovran Advisors investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Sovran Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Sovran Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 160k 18.14
2025-09-30 $3.3M 107k 30.46
2025-06-30 $1.3M 40k 31.36

More positions owned by Sovran Advisors

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Innovator Etfs Trust Us Eqty Ultra B (USEP)
Ishares Tr S&p 500 Val Etf (IVE)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)

View all positions for Sovran Advisors

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics